The 2030 notes will bear interest at 1.75% per annum, and the 2050 notes at 2.8% per year, said the drugmaker, which plans to use the proceeds to help repay the $1.5 billion loans it secured to to buy back its shares held by Sanofi (SNY). The offering is set to close on Aug. 12.
Price: 620.21, Change: 0.00, Percent Change: 0.00
|Insider Trends: Kindred Biosciences Insider Exercise...|
|Insider Trends: Insider at Ventas Gets Shares Award ...|
|Insider Trends: Ventas Insider Gets Shares Award Mak...|
|Insider Trends: 90-Day Insider Selling Trend Prolong...|
|Insider Trends: Insider at Minerals Technologies Acq...|